Akebia Therapeutics Inc. sell Global_Player
Start price
23.05.23
/
50%
€1.44
Target price
23.05.24
-
Performance (%)
-21.56%
End price
25.05.23
€1.13
Summary
This prediction ended on 25.05.23 with a price of €1.13. The prediction for Akebia Therapeutics Inc. closed with a convincing performance of -21.56%. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | 11.696% | 11.696% | -35.760% |
| iShares Core DAX® | -0.383% | 2.613% | 11.343% |
| iShares Nasdaq 100 | -0.411% | -2.005% | 5.353% |
| iShares Nikkei 225® | 1.838% | 9.391% | 33.529% |
| iShares S&P 500 | -0.712% | -0.476% | 2.508% |
According to Global_Player what are the pros and cons of Akebia Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Global_Player for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Sell Akebia Therapeutics Inc.